Recruitment: Pharmacists will systematically identify potential candidates by inviting all patients with type 2 diabetes receiving oral hypoglycemic medications to check their HbA1c using a point of care test. HbA1c is going to be measured in the pharmacy. The patient has to sign the first stage consent form in order to get his/her HbA1c measured. After signing the consent form, the patient's HbA1c will be measured using a digital meter which requires a blood spot which will be gained by pricking the patient's fingertip. If the result of HbA1c test is normal the patient will be given his/her result and told to keep up the good work. If the result of HbA1c test is high (7.5-11 %) and the patient meets the other inclusion criteria for the study the patient will be asked if he/she wants to participate in the study. If the patient agrees on participating in the study he/she will be asked to sign the second stage consent form. After signing the consent form the patient will be started on insulin glargine at bedtime and will be taught how to use the insulin pen. If HbA1c is > 11% the patient will be assessed by the study investigators, treatment recommendations will be checked and will be referred to his/her family physician.